Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02599818 · ClinicalTrials.gov registry record · NA
Navigation Services to Avoid Rehospitalization (NavSTAR)
A NA study, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT02599818: Completed NA study, sponsored by Friends Research Institute.
NCT02599818 is a NA study that has completed, run by Friends Research Institute. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02599818, a NA study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
This study will examine the clinical effectiveness and health economic profile of services to link hospital patients with substance use disorders to addiction treatment, promote their medical stabilization, and reduce hospital re-admissions.
Primary Outcome
Days to rehospitalization
Interventions
- BEHAVIORAL NavSTAR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2016-03-15 |
| Est. Completion | 2019-05-14 |
| Phase | NA |
What the finished NCT02599818 record still lists
NCT02599818 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which NavSTAR is the first listed.
NCT02599818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02599818 about?
NCT02599818 is a clinical study titled "Navigation Services to Avoid Rehospitalization (NavSTAR)". This study will examine the clinical effectiveness and health economic profile of services to link hospital patients with substance use disorders to addiction treatment, promote their medical stabilization, and reduce hospital re-admissions.
What is the current status of trial NCT02599818?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2016-03-15. Estimated completion is 2019-05-14.
What interventions are being tested in trial NCT02599818?
The interventions under investigation include: NavSTAR (BEHAVIORAL).
Who is sponsoring clinical trial NCT02599818?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02599818's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI